top of page
About Us
WHO WE ARE
About Us
RiboNova is a privately-held biopharmaceutical company based in the Lankenau Institute for Medical Research near Philadelphia, Pennsylvania.
Our Work
Our Work
Our product pipeline includes a Phase-2 ready small molecule drug for the treatment of all forms of genetically-confirmed mitochondrial disease.
In addition to this product candidate, we have a proprietary drug discovery platform that targets transfer RNA with novel precision medicines for the treatment of mitochondrial and other diseases.
Leadership Team
Leadership Team
Click picture for bio
Board of Directors
Board of Directors
Click picture for bio
Scientific Advisors
Scientific Advisors
Click picture for bio
bottom of page